Augmedix, Inc.
AUGX · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $45 | $31 | $22 | $16 |
| % Growth | 45% | 39.6% | 34.5% | – |
| Cost of Goods Sold | $23 | $17 | $12 | $10 |
| Gross Profit | $22 | $14 | $10 | $7 |
| % Margin | 48% | 45.1% | 45.1% | 41.2% |
| R&D Expenses | $11 | $10 | $7 | $5 |
| G&A Expenses | $18 | $17 | $14 | $12 |
| SG&A Expenses | $29 | $26 | $21 | $16 |
| Sales & Mktg Exp. | $11 | $9 | $8 | $4 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $40 | $36 | $28 | $20 |
| Operating Income | -$19 | -$22 | -$18 | -$14 |
| % Margin | -41.9% | -72.3% | -80.9% | -83.1% |
| Other Income/Exp. Net | -$0 | -$2 | $0 | -$2 |
| Pre-Tax Income | -$19 | -$24 | -$18 | -$16 |
| Tax Expense | $0 | $0 | -$1 | $0 |
| Net Income | -$19 | -$27 | -$17 | -$15 |
| % Margin | -42.7% | -85.8% | -77.4% | -89.4% |
| EPS | -0.44 | -0.71 | -0.59 | -0.56 |
| % Growth | 38% | -20.3% | -5.4% | – |
| EPS Diluted | -0.44 | -0.71 | -0.59 | -0.55 |
| Weighted Avg Shares Out | 44 | 37 | 29 | 26 |
| Weighted Avg Shares Out Dil | 44 | 37 | 29 | 27 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $0 |
| Interest Expense | $2 | $2 | $2 | $1 |
| Depreciation & Amortization | $1 | $2 | $1 | $1 |
| EBITDA | -$16 | -$22 | -$14 | -$13 |
| % Margin | -34.9% | -70.5% | -65.3% | -80.6% |